These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39082304)

  • 21. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Red cell distribution width-to-platelet ratio (RPR) as a predictor of prolonged stay at hospital for COVID-19 inpatients.
    Fors M; Ballaz SJ
    Future Sci OA; 2024 Dec; 10(1):2432180. PubMed ID: 39576020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant.
    Langer P; John L; Monsef I; Scheid C; Piechotta V; Skoetz N
    Cochrane Database Syst Rev; 2024 May; 5(5):CD013595. PubMed ID: 38695605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Point-of-care tests for urinary tract infections to reduce antimicrobial resistance: a systematic review and conceptual economic model.
    Tomlinson E; Ward M; Cooper C; James R; Stokes C; Begum S; Watson J; Hay AD; Jones HE; Thom H; Whiting P
    Health Technol Assess; 2024 Nov; 28(77):1-109. PubMed ID: 39644102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Pretreatment Neutrophil-to-Lymphocyte Ratio as a Near-Term Prognostic Indicator in Patients with Locally Advanced Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy: A Propensity Score Matching Cohort Study.
    Liu W; Zhang K; Chen S; Wang X; Yu W
    Br J Hosp Med (Lond); 2024 Nov; 85(11):1-16. PubMed ID: 39618219
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
    Filippini G; Del Giovane C; Vacchi L; D'Amico R; Di Pietrantonj C; Beecher D; Salanti G
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD008933. PubMed ID: 23744561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results.
    Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I
    Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity?
    Mu W; Xu B; Wahafu T; Wang F; Guo W; Zou C; Cao L
    Clin Orthop Relat Res; 2024 Dec; 482(12):2149-2160. PubMed ID: 38991223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive and Prognostic Value of Inflammatory and Nutritional Indexes in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy.
    Arici MO; Kivrak Salim D; Kocer M; Alparslan AS; Karakas BR; Ozturk B
    Medicina (Kaunas); 2024 Nov; 60(11):. PubMed ID: 39597034
    [No Abstract]   [Full Text] [Related]  

  • 31. [A real-world study of first-line albumin-bound paclitaxel in the treatment of advanced pancreatic cancer in China].
    Du J; Qiu X; Ni JY; Wang QL; Tong F; Sha HZ; Zhu YH; Qi L; Cai W; Gao C; Wei XW; Chen MB; Qian ZY; Cai MH; Tao M; Wang CL; Zheng GC; Jiang H; Dai AW; Wu J; Zhao MH; Li XQ; Lu B; Wang CB; Liu BR
    Zhonghua Zhong Liu Za Zhi; 2024 Nov; 46(11):1038-1048. PubMed ID: 39622736
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognostic value of systemic immune-inflammation index, neutrophil-lymphocyte ratio, and thrombocyte-lymphocyte ratio in critically ill patients with moderate to severe traumatic brain injury.
    Arslan K; Sahin AS
    Medicine (Baltimore); 2024 Jul; 103(29):e39007. PubMed ID: 39029062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Prognostic Role of Pre-Treatment Neutrophil-to-Lymphocyte Ratio in an Asian Cohort of Patients with Oropharyngeal Squamous Cell Carcinoma.
    Jang IJH; Abdul Kadir HB; Lim KH; Chew WCD; Hwang JSG; Lim CM
    Curr Oncol; 2024 Nov; 31(11):7074-7087. PubMed ID: 39590152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and systemic inflammatory index for detection of recurrence of pleomorphic adenoma of the major salivary glands: a multicenter study.
    Salzano G; Barone S; De Luca P; Borriello G; Vaira LA; Troise S; Granata V; Committeri U; Perri F; Esposito M; di Blasi F; Petrocelli M; Ionna F; Califano L; Orabona GD; Stadio AD
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2025 Jan; 139(1):73-79. PubMed ID: 39438185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-rich therapies for musculoskeletal soft tissue injuries.
    Moraes VY; Lenza M; Tamaoki MJ; Faloppa F; Belloti JC
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010071. PubMed ID: 24782334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of risk factors for cancer-specific survival in neoadjuvant chemotherapy nonresponsive disease of muscle-invasive bladder cancer: A multicentre study from the Turkish Urooncology Association Bladder Tumor study group.
    Teke K; Yılmaz H; Baltacı S; Akgül M; Şahin B; Türkeri L; Bozkurt O; Yücetaş U; Aslan G; Bolat D; İzol V; Özkan TA; Eskiçorapçi S;
    Urol Oncol; 2025 Jan; 43(1):61.e11-61.e18. PubMed ID: 39353827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Molecular Subgroups of Muscle-Invasive Urothelial Bladder Cancer and Their Impact on Treatment Outcome.
    Rashad AH; Abdel Hady HH; Assem A; Mohamed ME; Hamada E
    Asian Pac J Cancer Prev; 2024 Nov; 25(11):3953-3965. PubMed ID: 39611920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug therapy for obstructive sleep apnoea in adults.
    Mason M; Welsh EJ; Smith I
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD003002. PubMed ID: 23728641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of inflammatory blood markers and pathological complete response in HER2-positive breast cancer: a retrospective single-center cohort study.
    Chen X; Cai Q; Deng L; Chen M; Xu M; Chen L; Lin Y; Li Y; Wang Y; Chen H; Liu S; Wu J; Tong X; Fu F; Wang C
    Front Immunol; 2024; 15():1465862. PubMed ID: 39628488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival Outcomes in Patients With Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Chemotherapy Stratified by Number of Cycles.
    Chakraborty A; Hasler J; Handorf E; Anari F; Ghatalia P; Miron B; Plimack ER; Geynisman DM; Zibelman M
    Clin Genitourin Cancer; 2024 Dec; 22(6):102218. PubMed ID: 39388778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.